Tag archive for ‘Regeneron’
Jewish Business News On Tuesday, September 20th, 2016

Teva buys rights to Regeneron chronic pain drug for $250 million

Teva Pharmaceutical Industries  and Regeneron Pharmaceuticals. today announced an agreement to develop and commercialize pain drug fasinumab, Regeneron’s investigational NGF antibody in Phase 3 clinical More...

Wordpress site Developed by Fixing WordPress Problems